Tubulis
Marc-André Kasper is currently the Head of Research Chemistry at Tubulis. Marc-André was previously employed at FMP Berlin from November 2014 to March 2020, where they held the title of Wissenschaftlicher Mitarbeiter (Postdoktorand).
Marc-André Kasper has a Master of Science in Chemistry from Humboldt-Universität zu Berlin.
Marc-André Kasper reports to Jonas Helma-Smets, CSO. Swetlana Wunder - Technical Assistant Chemistry, Paul Machui - Technical Assistant Chemistry report to Marc-André Kasper. They are on a team with Marcus Gerlach - Head of Research Bioconjugation & Bioanalytics, Annette Vogl - Head of Research Biology.
This person is not in any offices
Tubulis
2 followers
Tubulis generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. Their goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) ushering in a new era and delivering better outcomes for patients. They will advance a range of conjugates, unlimited by indication, using their own discovery capabilities and by solving development challenges for partners with both antibody and chemical assets.